Publications by authors named "Chisato Ashida"

Claim this Profile
S
Stepwise dose reduction and discontinuation of bDMARD in rheumatoid arthritis: a prospective cohort study of flare-free population, flares, and predictive markers.
Yuji Nozaki, Kazuya Kishimoto, Daisuke Tomita, Tetsu Itami, Chisato Ashida

Arthritis Res Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of JAK Inhibitors for Rheumatoid Arthritis Patients with Poor-Prognosis Factors: The ANSWER Cohort Study.
Yuji Nozaki, Koichi Murata, Akira Onishi, Kohei Tsujimoto, Wataru Yamamoto, Chisato Ashida

Rheumatology (Oxford)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.
Kohei Tsujimoto, Kosuke Ebina, Satomi Okamura, Yasutaka Okita, Yuki Etani, Chisato Ashida

Rheumatology (Oxford)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.
Akira Onishi, Masao Tanaka, Takayuki Fujii, Koichi Murata, Kosaku Murakami, Chisato Ashida

Arthritis Res Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Kim-1 Correlates with Interstitial Nephritis Activity in Patients with Microscopic Polyangiitis.
Chisato Ashida, Yuji Nozaki, Jinhai Li, Hiroki Akazawa, Kazuya Kishimoto

Curr Issues Mol Biol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the GerdQ questionnaire in detecting gastroesophageal symptoms with RA patients.
Yuji Nozaki, Kazuya Kishimoto, Daisuke Tomita, Tetsu Itami, Chisato Ashida

BMC Rheumatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of IL-18Rα-mediated signaling pathway exacerbates neutrophil infiltration in imiquimod-induced psoriasis murine model.
Hiroki Akazawa, Yuji Nozaki, Hirotaka Yamazawa, Kaori Ishimura, Chisato Ashida

Front Med (Lausanne)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U-KIM-1 as a predictor of treatment response in lupus nephritis.
Yuji Nozaki, Toshihiko Shiga, Chisato Ashida, Daisuke Tomita, Tetsu Itami

Lupus· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.
Yuji Nozaki, Toshihiko Hidaka, Jinhai Ri, Tetsu Itami, Daisuke Tomita, Chisato Ashida

Front Med (Lausanne)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Chisato Ashida, Koji Kinoshita, Yuji Nozaki, Masanori Funauchi

BMC Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results.
Yuji Nozaki, Yasuaki Nagare, Chisato Ashida, Daisuke Tomita, Akinori Okada

Biologics· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis